128 related articles for article (PubMed ID: 34469597)
41. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
42. Overall and abdominal adiposity and premenopausal breast cancer risk among hispanic women: the breast cancer health disparities study.
John EM; Sangaramoorthy M; Hines LM; Stern MC; Baumgartner KB; Giuliano AR; Wolff RK; Slattery ML
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):138-47. PubMed ID: 25352526
[TBL] [Abstract][Full Text] [Related]
43. Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status.
Rosato V; Bosetti C; Negri E; Talamini R; Dal Maso L; Malvezzi M; Falcini F; Montella M; La Vecchia C
Eur J Cancer Prev; 2014 Sep; 23(5):412-7. PubMed ID: 23817433
[TBL] [Abstract][Full Text] [Related]
44. Progesterone receptor status modifies the association between body mass index and prognosis in women diagnosed with estrogen receptor positive breast cancer.
Oudanonh T; Nabi H; Ennour-Idrissi K; Lemieux J; Diorio C
Int J Cancer; 2020 May; 146(10):2736-2745. PubMed ID: 31403177
[TBL] [Abstract][Full Text] [Related]
45. Estrogen and progesterone receptor status in breast cancer: a cross-sectional study of 450 women in Kerala, South India.
Rajan G; Culas TB; Jayalakshmy PS
World J Surg Oncol; 2014 Apr; 12():120. PubMed ID: 24761803
[TBL] [Abstract][Full Text] [Related]
46. Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes.
Pedersen DC; Jensen BW; Tjønneland A; Andersen ZJ; Mellemkjaer L; Bjerregaard LG; Aarestrup J; Baker JL
Breast Cancer Res; 2022 Nov; 24(1):77. PubMed ID: 36369105
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
48. Association of breast cancer subtypes and body mass index.
Petekkaya I; Sahin U; Gezgen G; Solak M; Yuce D; Dizdar O; Arslan C; Ayyildiz V; Altundag K
Tumori; 2013; 99(2):129-33. PubMed ID: 23748802
[TBL] [Abstract][Full Text] [Related]
49. Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study.
Conroy SM; Pagano I; Kolonel LN; Maskarinec G
Cancer Epidemiol; 2011 Oct; 35(5):448-52. PubMed ID: 21247819
[TBL] [Abstract][Full Text] [Related]
50. Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study.
Bao PP; Shu XO; Gao YT; Zheng Y; Cai H; Deming SL; Ruan ZX; Su Y; Gu K; Lu W; Zheng W
Am J Epidemiol; 2011 Sep; 174(6):661-71. PubMed ID: 21768404
[TBL] [Abstract][Full Text] [Related]
51. Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer.
Xue C; Wei W; Sun P; Zheng W; Diao X; Xu F; Huang J; An X; Xia W; Hong R; Jiang K; Huang R; Yuan Z; Wang S; Li A; Zou R; Shi Y
Breast Cancer Res Treat; 2019 Feb; 173(3):619-628. PubMed ID: 30392113
[TBL] [Abstract][Full Text] [Related]
52. A case-control analysis of smoking and breast cancer in African American women: findings from the AMBER Consortium.
Park SY; Palmer JR; Rosenberg L; Haiman CA; Bandera EV; Bethea TN; Troester MA; Viscidi E; Kolonel LN; Olshan AF; Ambrosone CB
Carcinogenesis; 2016 Jun; 37(6):607-15. PubMed ID: 27207658
[TBL] [Abstract][Full Text] [Related]
53. Molecular Subtypes and Prognostic Factors among Premenopausal and Postmenopausal Thai Women with Invasive Breast Cancer: 15 Years Follow-up Data.
Tubtimhin S; Promthet S; Suwanrungruang K; Supaattagorn P
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3167-3174. PubMed ID: 30486605
[TBL] [Abstract][Full Text] [Related]
54. Body size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities study.
John EM; Sangaramoorthy M; Hines LM; Stern MC; Baumgartner KB; Giuliano AR; Wolff RK; Slattery ML
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):128-37. PubMed ID: 25352523
[TBL] [Abstract][Full Text] [Related]
55. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
[TBL] [Abstract][Full Text] [Related]
56. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
[TBL] [Abstract][Full Text] [Related]
57. Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status.
Zhang X; Eliassen AH; Tamimi RM; Hazra A; Beck AH; Brown M; Collins LC; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):962-8. PubMed ID: 25855627
[TBL] [Abstract][Full Text] [Related]
58. Height, sitting height, and leg length in relation with breast cancer risk in the E3N cohort.
Fagherazzi G; Vilier A; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1171-5. PubMed ID: 22623708
[TBL] [Abstract][Full Text] [Related]
59. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
60. Steroid receptor status and the epidemiology of breast cancer.
Kreiger N; King WD; Rosenberg L; Clarke EA; Palmer JR; Shapiro S
Ann Epidemiol; 1991 Nov; 1(6):513-23. PubMed ID: 1669531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
